1. Home
  2. Primary Antibodies

Search Result - Primary Antibodies

  • anti-CD21 antibody [LT21] (FITC)
  • Cat. No: ARG62772 　(Mouse mAb)
  • Reactivity: Hu, Dog, Pig, Bov
  • Application: FACS
  • Specificity: The clone LT21 reacts with CD21 (CR2), a 145 kDa transmembrane glycoprotein (complement C3d receptor - C3dR) expressed on B lymphocytes, follicular dendritic cells, some epithelial cells and a subsets of T lymphocytes. It is not expressed on immature B cells.
    HLDA VI; WS Code B CD21.1
  • Conjugation: FITC
  • anti-CD3 epsilon antibody [OKT3] (low endotoxin)
  • Cat. No: ARG62801 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-Fr, FuncSt
  • Specificity: The clone OKT3 recognizes the CD3 antigen of the TCR/CD3 complex on mature human T cells. This antibody, also known as Orthoclone OKT3 or Muromonab-CD3, has been extensively used as a drug for therapy of acute, glucocorticoid resistant rejection of allogenic renal, heart and liver transplants. It has also been investigated for use in treating T-cell acute lymphoblastic leukemia.
    HLDA VI; WS Code T6T-R3
  • Conjugation: Un-conjugated
  • anti-CD3 epsilon antibody [OKT3]
  • Cat. No: ARG62804 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-Fr, FuncSt
  • Specificity: The clone OKT3 recognizes the CD3 antigen of the TCR/CD3 complex on mature human T cells. This antibody, also known as Orthoclone OKT3 or Muromonab-CD3, has been extensively used as a drug for therapy of acute, glucocorticoid resistant rejection of allogenic renal, heart and liver transplants. It has also been investigated for use in treating T-cell acute lymphoblastic leukemia.
    HLDA VI; WS Code T6T-R3
  • Conjugation: Un-conjugated
  • anti-CD34 antibody [4H11(APG)]
  • Cat. No: ARG62820 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, ICC/IF, IHC-P, WB
  • Specificity: The clone 4H11(APG) reacts with Class III epitope on CD34 (Mucosialin), a 110-115 kDa monomeric transmembrane phosphoglycoprotein expressed on hematopoietic progenitors cells and on the most pluripotential stem cells; it is gradually lost on progenitor cells. 4H11(APG) completely blocks binding of Class II antibody QBEnd10 and Class III antibodies BIRMA K3 and 8G12 on KG1a cell line.
    HLDA VI; WS Code M MA58
  • Conjugation: Un-conjugated
  • anti-CD34 antibody [QBEND/10] (FITC)
  • Cat. No: ARG62822 　(Mouse mAb)
  • Reactivity: Hu, NHuPrm
  • Application: FACS
  • Specificity: The antibody recognizes the CD34 antigen, some cross reactions with vascular associated adventitia and some basement membranes. Clone QBEND/10 immunoprecipitates a glycoprotein with a relative MW 110kD expressed on haematopoietic cells and on the established myeloid leukaemic cell line KG1A. The clone QBEND/10 recognises the Class II epitope on CD34.
  • Conjugation: FITC
  • anti-CD4 antibody [MEM-115]
  • Cat. No: ARG62832 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IP, FuncSt
  • Specificity: The clone MEM-115 recognizes an epitope in the D1 domain of CD4 antigen, a 55 kDa transmebrane glycoprotein expressed on a subset of T lymphocytes (“helper“ T cells) and also on monocytes, tissue macrophages and granulocytes. It is negative in Western blotting even with non-reduced samples of cell lysates.
    HLDA V; WS Code T T-CD04.09
  • Conjugation: Un-conjugated
  • anti-CD41-CD61 Complex antibody [IVA30]
  • Cat. No: ARG62843 　(Mouse mAb)
  • Reactivity: Bov
  • Application: ELISA, FACS, ICC/IF, IP
  • Specificity: The clone IVA30 reacts with CD41/CD61 complex (bovine), one of the earliest markers of the megakaryocytic lineage. CD41/CD61 complex acts as the receptor for fibrinogen, fibronectin, Von Willebrand factor, vitronectin, thrombin and mediates platelets aggregation. CD41/CD61 is expressed only by platelets and megakaryocytes; the complex may be absent or strongly reduced in Glanzmann's thrombasthenia (GT).
  • Conjugation: Un-conjugated
  • anti-CD41 antibody [HIP8]
  • Cat. No: ARG62844 　(Mouse mAb)
  • Reactivity: Hu, NHuPrm
  • Application: FACS, IHC-Fr, CyTOF®-candidate
  • Specificity: The clone HIP8 reacts with alpha (a) subunit of CD41 (heavy chain; 120 kDa). CD41 is mainly expressed on platelets and megakaryocytes.
    HIP8 blocks platelet aggregation and completely inhibits ADP-, epinephrine-, and collagen-induced platelet activation, and partially inhibits ristocetin- and thrombin-induced platelet activation. HIP8 is useful in the morphological and physiological studies of platelets and megakaryocytes.
    HLDA IV; WS Code P 38
  • Conjugation: Un-conjugated
  • anti-CD44 antibody [MEM-85]
  • Cat. No: ARG62851 　(Mouse mAb)
  • Reactivity: Hu
  • Application: ELISA, FACS, IP, WB
  • Specificity: The clone MEM-85 reacts with both cell surface-expressed and soluble form of CD44 antigen (Phagocyte glycoprotein 1), a 80-95 kDa transmembrane glycoprotein (hyaladherin family) present on the most of cells and tissues (leukocytes, endothelial cells, mesenchymal cells, etc.); it is negative on platelets and hepatocytes.
    HLDA IV; WS Code NL 706
    HLDA VI; WS Code AS Ref.15
  • Conjugation: Un-conjugated
  • anti-CD48 antibody [MEM-102]
  • Cat. No: ARG62874 　(Mouse mAb)
  • Reactivity: Hu, NHuPrm
  • Application: FACS, IHC-P, IP, WB
  • Specificity: The clone MEM-102 reacts with CD48 antigen (Blast-1), a 40-47 kDa GPI-anchored membrane protein (immunoglobulin supergene family) widely expressed on hematopoietic cells; it is negative on granulocytes, platelets and erythrocytes.
    HLDA V; WS Code AS S014
  • Conjugation: Un-conjugated
arigo nuts about antibodies
© 2014-2025, arigo Biolaboratories Corp., All rights reserved